Wei Zhou
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Mayo Clinic(US)Xuzhou Medical College(CN)Wuhan University of Technology(CN)Changsha University(CN)Huzhou University(CN)Soochow University(CN)National Clinical Research Center for Digestive Diseases(CN)Nanfang Hospital(CN)Second People’s Hospital of Huai’an(CN)General Hospital of Shenyang Military Region(CN)Southern Medical University Shenzhen Hospital(CN)Central Hospital of Wuhan(CN)Wuhan General Hospital of Guangzhou(CN)Xijing Hospital(CN)Southern Medical University(CN)Wuhan Sports University(CN)Chongqing Medical University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Reproductive Biology and Fertility
Most-Cited Works
- → Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma(2012)986 cited
- → Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma(2013)527 cited
- → In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models(2009)472 cited
- Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis.(2001)
- → Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor.(1992)357 cited
- → A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor.(1994)268 cited
- → Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility